Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT01964534 · UNKNOWN
Trial details
- NCT number
- NCT01964534
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-12
- Primary completion
- 2017-02-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.